Skip to main content

EQT — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

300
Companies
$7.7B
Total invested
$150.7M
Avg. check
53
Industries
Health Care 9Medical 5Financial Services 5FinTech 5Biotechnology 5Artificial Intelligence (AI) 4+47 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 300
Pelago
March 2024

Pelago is a virtual clinic that offers virtual substance use care for adults and teens.

Health Care · New York$58.0M Series C
Hume AI
March 2024

Hume AI is a research lab and technology company building AI systems with emotional intelligence.

Artificial Intelligence (AI) · New York$50.0M Series B
Griffin
March 2024

Griffin is a banking-as-a-service provider that helps companies build and launch financial services products.

Banking · London$24.4M Series A
Phagenesis
March 2024

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Biotechnology · Manchester$42.0M Series D
Heart Aerospace
February 2024

Heart Aerospace is a Swedish startup making electric regional airplanes.

Aerospace · Goteborg$107.0M Series B
Packmatic
January 2024

Packmatic is a digital product packaging platform that sources packing solutions.

Digital Media · Berlin$16.3M Series A
Onera Health
January 2024

Onera Health is a global leader in sleep diagnostics and monitoring.

Health Care · Eindhoven$32.6M Series C
1X
January 2024

1X is an engineering and robotics company that develops humanoid robots designed to work alongside humans.

Artificial Intelligence (AI) · Moss$99.9M Series B
Vara
January 2024

Vara develops a breast cancer screening platform powered by AI.

Artificial Intelligence (AI) · Berlin$8.8M Series A
LUMA Vision
December 2023

LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.

Health Care · Harold's Cross$21.8M Series A
VectorY
November 2023

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Biotechnology · Amsterdam$138.0M Series A
Minervax
October 2023

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Biotechnology · Hellerup$57.4M Venture - Series Unknown
Billhop
September 2023

Billhop is a Payment Institution which enables businesses and consumers to Pay bills and invoices with your credit card.

Billing · Stockholm$7.9M Venture - Series Unknown
Xeltis
August 2023

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Health Care · Eindhoven$13.6M Series D
Volt.io
June 2023

Building the global infrastructure for real-time payments everywhere.

Financial Services · London$60.0M Series B
Finclude
May 2023

Transforming consumer credit based on transactional behaviour

Consumer Lending · Dublin$5K Grant
Ariceum Therapeutics
April 2023

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Biotechnology · Berlin$25.0M Series A
Noya
April 2023

Noya is reversing climate change and pulling CO2 out of the sky by retrofitting existing pieces of equipment to capture carbon.

Carbon Capture · San Francisco$22.0M Series A
QurAlis
March 2023

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Biotechnology · Cambridge$88.0M Series B
VECTARY
January 2023

VECTARY is a design platform that specializes in the fields of augmented reality, computer vision, and 3D technology.

3D Technology · Redwood City$4.6M Venture - Series Unknown
Anyfin
January 2023

Anyfin - a smart finance app that empowers people to understand and improve their finances.

Consumer Lending · Stockholm$31.3M Series C
Supernormal
January 2023

Supernormal is an AI platform that writes your meeting notes

Artificial Intelligence (AI) · Stockholm$10.0M Seed
Darkstore
December 2022

At Darkstore we build technology to power large scale micro fulfillment and instant delivery logistics.

Delivery · San Francisco$1.0M Undisclosed
Watt Fuel Cell
December 2022

WATT Fuel Cell is a developer and manufacturer of solid oxide fuel cell stacks.

Energy · Mount Pleasant Mills$82.3M Corporate Round

Where EQT invests

Health Care9
Medical5
Financial Services5
FinTech5
Biotechnology5
Artificial Intelligence (AI)4

About EQT's portfolio

How many companies has EQT invested in?▸

EQT has invested in 300 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EQT invest in?▸

EQT's top investment sectors include Health Care, Medical, Financial Services, FinTech, Biotechnology. The firm invests across 53 different industry categories.

What is EQT's largest investment?▸

Among tracked funding rounds, VectorY received $138.0M in a Series A round. EQT's total known invested capital is $7.7B.

What is the average investment size for EQT?▸

EQT's average investment size is $150.7M across its portfolio of 300 companies.

What are EQT's most recent investments?▸

Recent EQT portfolio additions include Pelago, Hume AI, Griffin, Phagenesis, Heart Aerospace. These companies were founded in 2020 or later.

Reach the founders behind these 300 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →